Dong-A Pharm to file a new drug application for DA-9601

Published: 2002-03-20 06:58:00

Updated: 2002-03-20 06:58:00

Dong-A Pharm, a drug manufacturer of Gaster (famotidine), has filed a new drug application for its gastric mucosa protective DA-9601 to the Korea Food and Drug Administration on March 15th, after completing its Phase III trials in the middle of last December.

Hanyang Securities says that the KFDA will grant its approval on DA-9601 within this August at the latest by shortening the proposed r...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.